发明申请
US20100256373A1 BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR
有权
作为组胺H4受体的调节剂的苯并咪唑基-2-YL吡啶和吡咯烷
- 专利标题： BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR
- 专利标题（中）： 作为组胺H4受体的调节剂的苯并咪唑基-2-YL吡啶和吡咯烷
-
申请号： US12816995申请日： 2010-06-16
-
公开(公告)号： US20100256373A1公开(公告)日： 2010-10-07
- 发明人: James P. EDWARDS , David E. KINDRACHUK , Christopher M. MAPES , Daniel J. PIPPEL , Jennifer D. VENABLE
- 申请人： James P. EDWARDS , David E. KINDRACHUK , Christopher M. MAPES , Daniel J. PIPPEL , Jennifer D. VENABLE
- 主分类号： C07D401/14
- IPC分类号： C07D401/14
摘要：
Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
公开/授权文献
信息查询
